| [1] |
Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of learning and memory by elevating brain magnesium [J]. Neuron, 2010, 65(2): 165-177.
|
| [2] |
Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review [J]. Stroke, 2009, 40(4): 1169-1175.
|
| [3] |
Katz A, Kerem D, Sherman D. Magnesium sulfate suppresses electroencephalographic manifestations of CNS oxygen toxicity [J]. Undersea biomedical research, 1990, 17(1): 45-49.
|
| [4] |
Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial [J]. The Lancet, 2002, 359(9321): 1877-1890.
|
| [5] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志，2020, 55(4): 227-238.
|
| [6] |
The American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia [J]. Obstet Gynecol, 2019, 133(1): e1-e25.
|
| [7] |
Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice [J]. Hypertension, 2018, 72(1): 24-43.
|
| [8] |
Long Q, Oladapo OT, Leathersich S, et al. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey [J]. BJOG, 2017, 124(12): 1883-1890.
|
| [9] |
林建华，乐怡平，庄旭. 子痫前期相关指南对解痉及抗凝治疗的推荐及临床困惑 [J]. 中华围产医学杂志，2015, 18(6): 414-417.
|
| [10] |
Duley L, Gülmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia [J]. Cochrane Database Syst Rev, 2010(11):1-83.
|
| [11] |
Mol BW, Roberts CT, Thangaratinam S, et al. Pre-eclampsia [J]. The Lancet, 2016, 387(10022): 999-1011.
|
| [12] |
杨孜，张为远．《妊娠期高血压疾病诊治指南(2020)》解读 [J]. 中华妇产科杂志，2020, 55(6): 425-432.
|
| [13] |
杨孜. 妊娠期高血压疾病中使用硫酸镁的种种问题及思考 [J]. 中国计划生育和妇产科，2017, 9(8): 1-4.
|
| [14] |
Ludmir J, Vigil-De Gracia P. 4: Is magnesium sulfate use of benefit post partum? A randomized controlled trial [J]．AJOG, 2017, 216(1 Suppl): S3-S4.
|
| [15] |
Vigil-De Gracia P, Ludmir J. The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period [J]. J Matern Fetal Neonatal Med, 2015, 28(18): 2207-2209.
|
| [16] |
Vigil-De Gracia P, Ramirez R, Durán Y, et al. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial [J]. BMC pregnancy and childbirth, 2017, 17(1): 1-6.
|
| [17] |
The U.S. Food and Drug Administration. FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies[EB/OL]．(2013-05-30)[2021-08-20]．
URL
|
| [18] |
The American College of Obstetricians and Gynecologists. Committee Opinion No 652: Magnesium Sulfate Use in Obstetrics [J]. Obstet Gynecol, 2016, 127(1): e52-e53.
|
| [19] |
Queensland Health. Queensland Clinical Guidelines (No. MN15.13-V6-R20.): Hypertensive disorders of pregnancy [DB/OL]. Queensland Government: Queensland, 2016 [2021-08-20].
URL
|
| [20] |
Miller EM, Sakowicz A, Leger E, et al. Association between Receipt of Intrapartum Magnesium Sulfate and Postpartum Hemorrhage [J]. AJP Rep, 2021, 11(1): e21-e25.
|
| [21] |
Stallworth JC, Yeh S-Y, Petrie RH. The effect of magnesium sulfate on fetal heart rate variability and uterine activity [J]. Am J Obstet Gynecol, 1981, 140(6): 702-706.
|
| [22] |
Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled tria l[J]. Am J Obstet Gynecol, 1997, 176(3): 623-627.
|
| [23] |
Héman L, Linden P. Does magnesium sulfate increase the incidence of postpartum hemorrhage? A systematic review [J]. Open Journal of Obstetrics and Gynecology, 2011, 1(4): 168-173.
|